WOLVERINE ASSET MANAGEMENT LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$291,005
+903.5%
28,841
+845.3%
0.00%–
Q3 2021$29,000–3,051–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders